Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 87 | 2024 | 3763 | 7.750 |
Why?
|
Quantitative Trait Loci | 26 | 2024 | 2116 | 4.960 |
Why?
|
HLA Antigens | 16 | 2024 | 1328 | 3.570 |
Why?
|
Genome-Wide Association Study | 107 | 2024 | 12690 | 3.540 |
Why?
|
Polymorphism, Single Nucleotide | 113 | 2024 | 15936 | 3.460 |
Why?
|
Genetic Predisposition to Disease | 118 | 2024 | 17904 | 3.440 |
Why?
|
Synovial Membrane | 14 | 2024 | 532 | 3.230 |
Why?
|
Autoimmune Diseases | 14 | 2024 | 2244 | 2.510 |
Why?
|
Psoriasis | 20 | 2024 | 950 | 2.480 |
Why?
|
Single-Cell Analysis | 19 | 2024 | 2449 | 2.150 |
Why?
|
Alleles | 57 | 2024 | 6863 | 2.070 |
Why?
|
Genetic Variation | 34 | 2024 | 6567 | 1.970 |
Why?
|
Linkage Disequilibrium | 22 | 2021 | 1998 | 1.870 |
Why?
|
Rheumatic Diseases | 6 | 2021 | 649 | 1.820 |
Why?
|
Fibroblasts | 15 | 2024 | 4141 | 1.660 |
Why?
|
Chromosome Mapping | 21 | 2024 | 4615 | 1.660 |
Why?
|
Genetic Loci | 32 | 2021 | 2632 | 1.480 |
Why?
|
Regulatory Sequences, Nucleic Acid | 4 | 2024 | 790 | 1.390 |
Why?
|
Chromatin | 8 | 2024 | 2960 | 1.390 |
Why?
|
Macular Degeneration | 13 | 2016 | 1007 | 1.360 |
Why?
|
Histocompatibility Antigens Class I | 5 | 2023 | 1349 | 1.330 |
Why?
|
Mycobacterium tuberculosis | 7 | 2024 | 1914 | 1.310 |
Why?
|
Haplotypes | 23 | 2023 | 2713 | 1.270 |
Why?
|
Gene Expression Regulation | 22 | 2024 | 11903 | 1.270 |
Why?
|
Genetics, Population | 4 | 2021 | 937 | 1.270 |
Why?
|
Molecular Sequence Annotation | 7 | 2020 | 522 | 1.240 |
Why?
|
Major Histocompatibility Complex | 7 | 2014 | 870 | 1.240 |
Why?
|
T-Lymphocyte Subsets | 7 | 2023 | 1802 | 1.220 |
Why?
|
CD4-Positive T-Lymphocytes | 13 | 2024 | 4369 | 1.160 |
Why?
|
Rheumatology | 4 | 2022 | 615 | 1.160 |
Why?
|
Autoimmunity | 7 | 2024 | 1356 | 1.150 |
Why?
|
HLA-B Antigens | 7 | 2020 | 317 | 1.130 |
Why?
|
Host-Pathogen Interactions | 5 | 2024 | 1459 | 1.130 |
Why?
|
Receptors, Antigen, T-Cell | 5 | 2024 | 2547 | 1.040 |
Why?
|
Phenotype | 25 | 2024 | 16591 | 1.020 |
Why?
|
Amino Acids | 10 | 2023 | 1718 | 1.020 |
Why?
|
Genome, Human | 19 | 2023 | 4425 | 1.010 |
Why?
|
Disease | 4 | 2016 | 672 | 0.960 |
Why?
|
Genotype | 42 | 2024 | 12990 | 0.920 |
Why?
|
Diabetes Mellitus, Type 1 | 9 | 2021 | 3415 | 0.880 |
Why?
|
Complement Factor H | 7 | 2016 | 110 | 0.870 |
Why?
|
Selection, Genetic | 5 | 2021 | 868 | 0.870 |
Why?
|
Tumor Necrosis Factor-alpha | 12 | 2024 | 4352 | 0.850 |
Why?
|
B-Lymphocytes | 8 | 2024 | 4758 | 0.840 |
Why?
|
Peru | 6 | 2024 | 891 | 0.820 |
Why?
|
T-Lymphocytes | 9 | 2024 | 10194 | 0.820 |
Why?
|
Humans | 259 | 2024 | 761504 | 0.800 |
Why?
|
Physical Chromosome Mapping | 2 | 2021 | 183 | 0.790 |
Why?
|
Arthritis, Psoriatic | 4 | 2022 | 219 | 0.790 |
Why?
|
Stromal Cells | 4 | 2022 | 1330 | 0.780 |
Why?
|
Histocompatibility Antigens Class II | 6 | 2023 | 1435 | 0.780 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2021 | 2155 | 0.770 |
Why?
|
Monocytes | 6 | 2022 | 2570 | 0.770 |
Why?
|
Interleukin-17 | 2 | 2020 | 912 | 0.750 |
Why?
|
Tuberculosis | 3 | 2024 | 2017 | 0.750 |
Why?
|
Software | 9 | 2021 | 4434 | 0.750 |
Why?
|
Gene Frequency | 19 | 2021 | 3606 | 0.740 |
Why?
|
Multifactorial Inheritance | 7 | 2022 | 1387 | 0.730 |
Why?
|
Cytokines | 8 | 2023 | 7396 | 0.730 |
Why?
|
Case-Control Studies | 44 | 2021 | 22176 | 0.730 |
Why?
|
Genetic Pleiotropy | 3 | 2016 | 181 | 0.710 |
Why?
|
Antirheumatic Agents | 11 | 2024 | 1372 | 0.710 |
Why?
|
Genome | 4 | 2023 | 1740 | 0.710 |
Why?
|
Computational Biology | 16 | 2021 | 3518 | 0.710 |
Why?
|
Genomics | 11 | 2023 | 5821 | 0.700 |
Why?
|
Quantitative Trait, Heritable | 4 | 2021 | 543 | 0.700 |
Why?
|
Gene Expression Profiling | 18 | 2024 | 9420 | 0.690 |
Why?
|
Lupus Nephritis | 5 | 2022 | 316 | 0.690 |
Why?
|
Immunologic Memory | 3 | 2021 | 1359 | 0.670 |
Why?
|
HLA-C Antigens | 3 | 2022 | 140 | 0.650 |
Why?
|
Celiac Disease | 7 | 2022 | 821 | 0.650 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2021 | 832 | 0.640 |
Why?
|
HLA-D Antigens | 2 | 2016 | 129 | 0.630 |
Why?
|
Genetic Markers | 3 | 2016 | 2601 | 0.630 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 800 | 0.610 |
Why?
|
Flow Cytometry | 9 | 2020 | 5869 | 0.600 |
Why?
|
Immune System Diseases | 5 | 2019 | 256 | 0.600 |
Why?
|
Complement Factor I | 2 | 2015 | 14 | 0.580 |
Why?
|
Genes | 5 | 2019 | 1823 | 0.580 |
Why?
|
Mutation, Missense | 5 | 2020 | 2571 | 0.580 |
Why?
|
Keratinocytes | 5 | 2019 | 790 | 0.570 |
Why?
|
Meta-Analysis as Topic | 8 | 2016 | 1380 | 0.570 |
Why?
|
Body Height | 3 | 2020 | 1570 | 0.560 |
Why?
|
Repressor Proteins | 4 | 2020 | 2986 | 0.560 |
Why?
|
Databases, Genetic | 12 | 2021 | 1742 | 0.550 |
Why?
|
Complement C3 | 2 | 2021 | 435 | 0.550 |
Why?
|
Th17 Cells | 2 | 2021 | 794 | 0.550 |
Why?
|
Gene Deletion | 4 | 2013 | 2665 | 0.510 |
Why?
|
Blood Cells | 1 | 2017 | 305 | 0.500 |
Why?
|
Macrophages | 5 | 2024 | 5769 | 0.500 |
Why?
|
Nerve Growth Factor | 3 | 2009 | 158 | 0.500 |
Why?
|
Epigenomics | 2 | 2019 | 943 | 0.500 |
Why?
|
Transcription Factors | 6 | 2024 | 12128 | 0.490 |
Why?
|
Arthritis, Experimental | 1 | 2017 | 291 | 0.480 |
Why?
|
Enhancer Elements, Genetic | 2 | 2020 | 1363 | 0.470 |
Why?
|
Receptors, Interleukin-17 | 1 | 2014 | 82 | 0.470 |
Why?
|
Complement C9 | 1 | 2013 | 15 | 0.460 |
Why?
|
Genes, Fungal | 4 | 2003 | 439 | 0.450 |
Why?
|
Amino Acid Substitution | 5 | 2017 | 1738 | 0.440 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2898 | 0.430 |
Why?
|
Models, Genetic | 10 | 2021 | 3442 | 0.420 |
Why?
|
Immune System | 2 | 2016 | 796 | 0.420 |
Why?
|
Inflammation | 11 | 2023 | 10773 | 0.420 |
Why?
|
Dermatitis | 3 | 2001 | 202 | 0.420 |
Why?
|
Genetic Heterogeneity | 4 | 2016 | 732 | 0.420 |
Why?
|
Inflammatory Bowel Diseases | 5 | 2024 | 2422 | 0.410 |
Why?
|
Research Design | 4 | 2023 | 6180 | 0.400 |
Why?
|
Blood Proteins | 2 | 2024 | 1173 | 0.400 |
Why?
|
Crohn Disease | 9 | 2024 | 2279 | 0.400 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 5789 | 0.400 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1860 | 0.400 |
Why?
|
Cluster Analysis | 7 | 2022 | 2707 | 0.390 |
Why?
|
Arthritis | 4 | 2024 | 680 | 0.380 |
Why?
|
Algorithms | 17 | 2021 | 14031 | 0.380 |
Why?
|
Natural Killer T-Cells | 2 | 2019 | 322 | 0.380 |
Why?
|
Complementarity Determining Regions | 2 | 2022 | 149 | 0.380 |
Why?
|
Lymphocyte Activation | 4 | 2024 | 5486 | 0.380 |
Why?
|
Schizophrenia | 9 | 2019 | 6937 | 0.380 |
Why?
|
Calcium Channels, L-Type | 2 | 2014 | 242 | 0.370 |
Why?
|
Immunophenotyping | 5 | 2019 | 1870 | 0.370 |
Why?
|
Disease Progression | 8 | 2021 | 13506 | 0.360 |
Why?
|
Complement C3b Inactivator Proteins | 1 | 2010 | 13 | 0.360 |
Why?
|
Gene Expression | 8 | 2020 | 7581 | 0.360 |
Why?
|
Genetic Association Studies | 10 | 2021 | 2735 | 0.360 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2416 | 0.360 |
Why?
|
Autoantibodies | 13 | 2020 | 2116 | 0.350 |
Why?
|
Sequence Analysis, RNA | 4 | 2024 | 2020 | 0.350 |
Why?
|
Risk | 9 | 2019 | 9610 | 0.350 |
Why?
|
Skin | 9 | 2023 | 4484 | 0.340 |
Why?
|
Penetrance | 1 | 2011 | 383 | 0.340 |
Why?
|
Receptor, Nerve Growth Factor | 1 | 2009 | 48 | 0.330 |
Why?
|
Inheritance Patterns | 6 | 2020 | 341 | 0.330 |
Why?
|
Jurkat Cells | 3 | 2019 | 740 | 0.320 |
Why?
|
Genome, Bacterial | 3 | 2024 | 783 | 0.320 |
Why?
|
Chemokine CCL5 | 2 | 2000 | 214 | 0.320 |
Why?
|
Anti-Inflammatory Agents | 2 | 2017 | 1809 | 0.310 |
Why?
|
Oligonucleotide Array Sequence Analysis | 9 | 2012 | 3778 | 0.310 |
Why?
|
Receptor, trkA | 1 | 2009 | 159 | 0.300 |
Why?
|
Chromosomes, Human | 2 | 2018 | 441 | 0.300 |
Why?
|
Risk Factors | 38 | 2023 | 74206 | 0.290 |
Why?
|
Colitis, Ulcerative | 6 | 2024 | 1922 | 0.290 |
Why?
|
Models, Molecular | 4 | 2016 | 5439 | 0.290 |
Why?
|
Male | 82 | 2024 | 360804 | 0.280 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2020 | 64 | 0.280 |
Why?
|
Inflammasomes | 1 | 2012 | 526 | 0.280 |
Why?
|
Base Sequence | 5 | 2020 | 12441 | 0.280 |
Why?
|
Polymorphism, Genetic | 4 | 2022 | 4243 | 0.280 |
Why?
|
Nervous System Diseases | 2 | 2012 | 1666 | 0.270 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2022 | 12148 | 0.270 |
Why?
|
Methotrexate | 4 | 2024 | 1719 | 0.270 |
Why?
|
Drug Discovery | 2 | 2013 | 1051 | 0.260 |
Why?
|
Pharmacogenetics | 1 | 2010 | 675 | 0.260 |
Why?
|
Antibodies, Monoclonal | 3 | 2014 | 9177 | 0.260 |
Why?
|
Multiprotein Complexes | 1 | 2012 | 1118 | 0.250 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5336 | 0.250 |
Why?
|
Spondylitis, Ankylosing | 2 | 2018 | 155 | 0.250 |
Why?
|
Peptides, Cyclic | 7 | 2017 | 392 | 0.250 |
Why?
|
Principal Component Analysis | 4 | 2018 | 943 | 0.250 |
Why?
|
Cell Shape | 2 | 2024 | 371 | 0.240 |
Why?
|
Thioredoxin-Disulfide Reductase | 1 | 2024 | 52 | 0.240 |
Why?
|
DNA Copy Number Variations | 2 | 2010 | 2020 | 0.240 |
Why?
|
Female | 75 | 2024 | 392644 | 0.240 |
Why?
|
Models, Statistical | 3 | 2016 | 5079 | 0.240 |
Why?
|
RNA, Messenger | 3 | 2018 | 12795 | 0.240 |
Why?
|
Animals | 28 | 2024 | 168459 | 0.230 |
Why?
|
Natural Language Processing | 3 | 2003 | 1162 | 0.230 |
Why?
|
Opportunistic Infections | 1 | 2007 | 376 | 0.230 |
Why?
|
Regulatory Elements, Transcriptional | 2 | 2015 | 183 | 0.230 |
Why?
|
Depressive Disorder, Major | 3 | 2024 | 4761 | 0.230 |
Why?
|
Histones | 5 | 2019 | 2580 | 0.220 |
Why?
|
Skin Diseases | 1 | 2012 | 1094 | 0.220 |
Why?
|
Synovial Fluid | 3 | 2020 | 393 | 0.210 |
Why?
|
Epistasis, Genetic | 2 | 2015 | 352 | 0.210 |
Why?
|
Joints | 4 | 2019 | 322 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3051 | 0.210 |
Why?
|
Receptors, Glucocorticoid | 1 | 2024 | 305 | 0.210 |
Why?
|
Transcription Factor AP-1 | 1 | 2024 | 321 | 0.210 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3802 | 0.210 |
Why?
|
Rheumatoid Factor | 3 | 2024 | 185 | 0.210 |
Why?
|
Interleukin-16 | 1 | 2022 | 34 | 0.200 |
Why?
|
Open Reading Frames | 2 | 2017 | 815 | 0.200 |
Why?
|
Glomerulonephritis, IGA | 1 | 2022 | 63 | 0.200 |
Why?
|
Genetic Diseases, Inborn | 2 | 2019 | 604 | 0.200 |
Why?
|
Mutant Proteins | 1 | 2024 | 491 | 0.200 |
Why?
|
Chemokines, CX3C | 1 | 2001 | 12 | 0.190 |
Why?
|
T-Box Domain Proteins | 1 | 2024 | 469 | 0.190 |
Why?
|
Sequence Alignment | 2 | 2003 | 2180 | 0.190 |
Why?
|
Burkitt Lymphoma | 1 | 2024 | 335 | 0.190 |
Why?
|
Biopsy | 6 | 2023 | 6766 | 0.190 |
Why?
|
Allergy and Immunology | 1 | 2013 | 176 | 0.190 |
Why?
|
Citrulline | 3 | 2017 | 106 | 0.180 |
Why?
|
Receptors, CCR2 | 1 | 2022 | 215 | 0.180 |
Why?
|
Sex Factors | 7 | 2021 | 10552 | 0.180 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2021 | 113 | 0.180 |
Why?
|
HLA-DQ Antigens | 1 | 2021 | 191 | 0.180 |
Why?
|
Signal Transduction | 10 | 2024 | 23445 | 0.180 |
Why?
|
Cells, Cultured | 7 | 2020 | 18965 | 0.180 |
Why?
|
Computer Simulation | 7 | 2022 | 6240 | 0.180 |
Why?
|
Complement C4 | 1 | 2021 | 217 | 0.180 |
Why?
|
Microfibrils | 1 | 2020 | 16 | 0.180 |
Why?
|
Esters | 1 | 2021 | 211 | 0.180 |
Why?
|
Dendritic Cells | 3 | 2024 | 2747 | 0.180 |
Why?
|
Chromosomes | 1 | 2023 | 577 | 0.180 |
Why?
|
Indians, South American | 1 | 2020 | 34 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.180 |
Why?
|
Mice | 17 | 2024 | 81525 | 0.180 |
Why?
|
Adult | 42 | 2024 | 221177 | 0.180 |
Why?
|
Saccharomyces cerevisiae | 5 | 2003 | 2688 | 0.180 |
Why?
|
Middle Aged | 41 | 2024 | 220895 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2019 | 3639 | 0.180 |
Why?
|
Chemokine CXCL2 | 1 | 2020 | 106 | 0.170 |
Why?
|
Sulfhydryl Compounds | 1 | 2021 | 301 | 0.170 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2022 | 344 | 0.170 |
Why?
|
Severity of Illness Index | 8 | 2015 | 15842 | 0.170 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2017 | 1334 | 0.170 |
Why?
|
Chemokine CXCL1 | 1 | 2020 | 101 | 0.170 |
Why?
|
Heredity | 1 | 2020 | 148 | 0.170 |
Why?
|
Viral Load | 2 | 2021 | 3332 | 0.170 |
Why?
|
Antigens, CD | 3 | 2019 | 4003 | 0.170 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2020 | 138 | 0.170 |
Why?
|
Chemotactic Factors | 1 | 2020 | 197 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2024 | 4580 | 0.160 |
Why?
|
Peptides | 2 | 2022 | 4358 | 0.160 |
Why?
|
Myositis | 1 | 2022 | 271 | 0.160 |
Why?
|
Dermatomyositis | 1 | 2022 | 258 | 0.160 |
Why?
|
Electronic Health Records | 6 | 2022 | 4811 | 0.160 |
Why?
|
Nephrotic Syndrome | 1 | 2023 | 390 | 0.160 |
Why?
|
Neutrophil Infiltration | 1 | 2021 | 390 | 0.160 |
Why?
|
Public-Private Sector Partnerships | 1 | 2020 | 122 | 0.160 |
Why?
|
Cell Proliferation | 4 | 2021 | 10445 | 0.160 |
Why?
|
Endothelial Cells | 3 | 2022 | 3548 | 0.160 |
Why?
|
Amides | 1 | 2021 | 449 | 0.160 |
Why?
|
Transcription Factor RelA | 1 | 2020 | 254 | 0.160 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2021 | 755 | 0.160 |
Why?
|
Metabolic Networks and Pathways | 3 | 2012 | 789 | 0.160 |
Why?
|
Neutrophils | 2 | 2021 | 3767 | 0.160 |
Why?
|
Pemphigus | 1 | 2019 | 107 | 0.160 |
Why?
|
Neuroimmunomodulation | 1 | 2000 | 182 | 0.160 |
Why?
|
Mesenchymal Stem Cells | 2 | 2020 | 1642 | 0.150 |
Why?
|
Foot Joints | 2 | 2015 | 35 | 0.150 |
Why?
|
Nerve Growth Factors | 2 | 1999 | 564 | 0.150 |
Why?
|
Rheumatic Fever | 2 | 2015 | 73 | 0.150 |
Why?
|
Chemokines, CXC | 1 | 2020 | 422 | 0.150 |
Why?
|
Receptors, IgG | 1 | 2021 | 559 | 0.150 |
Why?
|
Hand Joints | 2 | 2015 | 58 | 0.150 |
Why?
|
Kidney | 4 | 2022 | 7048 | 0.150 |
Why?
|
Reference Standards | 1 | 2021 | 1003 | 0.150 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4740 | 0.150 |
Why?
|
Interleukin-1 | 1 | 2021 | 1248 | 0.150 |
Why?
|
Organ Specificity | 3 | 2017 | 1967 | 0.150 |
Why?
|
Adipocytes | 1 | 2024 | 1194 | 0.150 |
Why?
|
High-Throughput Screening Assays | 3 | 2018 | 934 | 0.150 |
Why?
|
Antigen-Presenting Cells | 1 | 2001 | 964 | 0.150 |
Why?
|
Nasal Polyps | 1 | 2023 | 395 | 0.140 |
Why?
|
Biotechnology | 1 | 2019 | 282 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2024 | 612 | 0.140 |
Why?
|
Lichen Planus | 1 | 1998 | 70 | 0.140 |
Why?
|
Information Storage and Retrieval | 1 | 2003 | 819 | 0.140 |
Why?
|
Chemokines | 2 | 2020 | 960 | 0.140 |
Why?
|
Biological Products | 3 | 2022 | 914 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2022 | 3080 | 0.140 |
Why?
|
Kidney Tubules | 1 | 2019 | 449 | 0.140 |
Why?
|
Genetic Linkage | 3 | 2013 | 2341 | 0.140 |
Why?
|
Chymotrypsin | 1 | 2016 | 138 | 0.140 |
Why?
|
Neurons, Afferent | 2 | 1998 | 498 | 0.140 |
Why?
|
HLA-DR Antigens | 1 | 2018 | 602 | 0.140 |
Why?
|
Amino Acid Oxidoreductases | 1 | 2017 | 149 | 0.140 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 477 | 0.140 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5796 | 0.140 |
Why?
|
Scleroderma, Systemic | 2 | 2018 | 344 | 0.140 |
Why?
|
Complement Activation | 2 | 2021 | 445 | 0.140 |
Why?
|
Logistic Models | 4 | 2017 | 13255 | 0.140 |
Why?
|
Bruch Membrane | 1 | 2016 | 65 | 0.140 |
Why?
|
Hydrocortisone | 1 | 2024 | 1819 | 0.140 |
Why?
|
Cohort Studies | 15 | 2024 | 41487 | 0.140 |
Why?
|
Gases | 1 | 1997 | 204 | 0.140 |
Why?
|
Bipolar Disorder | 3 | 2018 | 5092 | 0.130 |
Why?
|
Apyrase | 1 | 2019 | 373 | 0.130 |
Why?
|
Cholangitis, Sclerosing | 2 | 2016 | 177 | 0.130 |
Why?
|
Japan | 5 | 2020 | 1378 | 0.130 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2024 | 974 | 0.130 |
Why?
|
Retinal Drusen | 1 | 2016 | 74 | 0.130 |
Why?
|
Exfoliation Syndrome | 1 | 2017 | 113 | 0.130 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2016 | 48 | 0.130 |
Why?
|
Herpes Zoster | 1 | 2018 | 253 | 0.130 |
Why?
|
Mice, Inbred DBA | 1 | 2017 | 621 | 0.130 |
Why?
|
Protein Binding | 5 | 2021 | 9351 | 0.130 |
Why?
|
Enzymes | 1 | 1997 | 257 | 0.130 |
Why?
|
CCN Intercellular Signaling Proteins | 1 | 2015 | 24 | 0.130 |
Why?
|
Gene Regulatory Networks | 3 | 2022 | 1745 | 0.130 |
Why?
|
Cell Lineage | 2 | 2022 | 2555 | 0.130 |
Why?
|
Medical Records | 1 | 2021 | 1408 | 0.130 |
Why?
|
Eye Diseases, Hereditary | 1 | 2016 | 122 | 0.120 |
Why?
|
TYK2 Kinase | 1 | 2015 | 38 | 0.120 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2200 | 0.120 |
Why?
|
Interferon Type I | 1 | 2019 | 562 | 0.120 |
Why?
|
Finger Joint | 1 | 2015 | 108 | 0.120 |
Why?
|
Rhinitis | 1 | 2023 | 747 | 0.120 |
Why?
|
Aged | 25 | 2024 | 169289 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2161 | 0.120 |
Why?
|
Group II Chaperonins | 1 | 2014 | 7 | 0.120 |
Why?
|
Pericytes | 1 | 2018 | 293 | 0.120 |
Why?
|
Models, Biological | 3 | 2022 | 9469 | 0.120 |
Why?
|
HIV Infections | 1 | 2021 | 17351 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2024 | 2909 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 1351 | 0.120 |
Why?
|
Neuropeptides | 3 | 2000 | 944 | 0.120 |
Why?
|
Research | 2 | 2010 | 1982 | 0.120 |
Why?
|
Smoking | 4 | 2020 | 9053 | 0.120 |
Why?
|
Genes, MHC Class II | 1 | 2015 | 434 | 0.120 |
Why?
|
Amino Acid Sequence | 3 | 2021 | 13446 | 0.120 |
Why?
|
Protein Structure, Secondary | 1 | 1997 | 1229 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2021 | 966 | 0.120 |
Why?
|
Interferon Regulatory Factor-7 | 1 | 2014 | 36 | 0.120 |
Why?
|
DNA, Intergenic | 1 | 2014 | 105 | 0.120 |
Why?
|
Leukocytes | 2 | 2019 | 2026 | 0.120 |
Why?
|
Lymphocytes | 2 | 2019 | 2612 | 0.110 |
Why?
|
Workflow | 1 | 2019 | 851 | 0.110 |
Why?
|
Lysophospholipase | 1 | 2014 | 66 | 0.110 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1560 | 0.110 |
Why?
|
Gene Dosage | 3 | 2021 | 1217 | 0.110 |
Why?
|
Epitopes | 3 | 2015 | 2503 | 0.110 |
Why?
|
Cardiomegaly | 1 | 2016 | 590 | 0.110 |
Why?
|
Pedigree | 3 | 2016 | 4542 | 0.110 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18252 | 0.110 |
Why?
|
Indians, North American | 1 | 2017 | 352 | 0.110 |
Why?
|
Neoplasm Proteins | 3 | 2017 | 3617 | 0.110 |
Why?
|
Sinusitis | 1 | 2023 | 991 | 0.110 |
Why?
|
Mendelian Randomization Analysis | 2 | 2016 | 1007 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1089 | 0.110 |
Why?
|
Th1 Cells | 1 | 2018 | 1036 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1993 | 0.110 |
Why?
|
STAT Transcription Factors | 1 | 2014 | 188 | 0.110 |
Why?
|
HLA-B8 Antigen | 1 | 2012 | 16 | 0.110 |
Why?
|
Semaphorins | 1 | 2013 | 96 | 0.110 |
Why?
|
Colon | 1 | 2021 | 1792 | 0.110 |
Why?
|
Interleukin-23 | 1 | 2014 | 201 | 0.110 |
Why?
|
Typhoid Fever | 1 | 2014 | 194 | 0.110 |
Why?
|
Models, Theoretical | 5 | 2021 | 3575 | 0.110 |
Why?
|
Skin Diseases, Infectious | 1 | 1993 | 76 | 0.110 |
Why?
|
Proteomics | 3 | 2022 | 3849 | 0.100 |
Why?
|
Osteoporosis | 2 | 2013 | 1606 | 0.100 |
Why?
|
Autistic Disorder | 1 | 2022 | 1220 | 0.100 |
Why?
|
HEK293 Cells | 2 | 2019 | 4278 | 0.100 |
Why?
|
Erythroid Cells | 1 | 2014 | 238 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 918 | 0.100 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 161 | 0.100 |
Why?
|
Hydrolases | 1 | 2013 | 147 | 0.100 |
Why?
|
Models, Immunological | 1 | 2014 | 513 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 2013 | 321 | 0.100 |
Why?
|
Outpatients | 1 | 2020 | 1597 | 0.100 |
Why?
|
Genes, Recessive | 1 | 2014 | 623 | 0.100 |
Why?
|
Consanguinity | 1 | 2014 | 456 | 0.100 |
Why?
|
Serine Endopeptidases | 2 | 2019 | 1022 | 0.100 |
Why?
|
Point Mutation | 1 | 2017 | 1595 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2016 | 1897 | 0.100 |
Why?
|
Collagen Type X | 1 | 2011 | 16 | 0.100 |
Why?
|
Joint Diseases | 1 | 2015 | 459 | 0.100 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 917 | 0.100 |
Why?
|
Fibrinogen | 1 | 2015 | 888 | 0.100 |
Why?
|
Databases, Nucleic Acid | 1 | 2012 | 205 | 0.100 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2012 | 108 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 2011 | 71 | 0.090 |
Why?
|
HIV-1 | 2 | 2021 | 6863 | 0.090 |
Why?
|
Geographic Atrophy | 1 | 2012 | 91 | 0.090 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2013 | 600 | 0.090 |
Why?
|
Complement System Proteins | 1 | 2014 | 736 | 0.090 |
Why?
|
Mycobacterium | 1 | 2012 | 251 | 0.090 |
Why?
|
Stress, Psychological | 4 | 2000 | 4481 | 0.090 |
Why?
|
Age Factors | 2 | 2021 | 18395 | 0.090 |
Why?
|
Proline | 1 | 2012 | 457 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 340 | 0.090 |
Why?
|
Interleukin-2 | 2 | 2023 | 1889 | 0.090 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3429 | 0.090 |
Why?
|
Loss of Heterozygosity | 1 | 2013 | 662 | 0.090 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 418 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1589 | 0.090 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7594 | 0.090 |
Why?
|
Mice, Knockout | 4 | 2024 | 14414 | 0.090 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 642 | 0.090 |
Why?
|
Twin Studies as Topic | 1 | 2010 | 103 | 0.090 |
Why?
|
Europe | 4 | 2020 | 3422 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.090 |
Why?
|
Alanine | 1 | 2012 | 609 | 0.080 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2011 | 159 | 0.080 |
Why?
|
Myasthenia Gravis | 1 | 2012 | 214 | 0.080 |
Why?
|
Substance P | 3 | 2000 | 335 | 0.080 |
Why?
|
Long QT Syndrome | 1 | 2014 | 467 | 0.080 |
Why?
|
Calcium Signaling | 1 | 2014 | 733 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 638 | 0.080 |
Why?
|
Child | 11 | 2024 | 80153 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2016 | 683 | 0.080 |
Why?
|
Computer Graphics | 1 | 2011 | 340 | 0.080 |
Why?
|
Histocompatibility Testing | 2 | 2021 | 712 | 0.080 |
Why?
|
Psychoneuroimmunology | 2 | 2000 | 13 | 0.080 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 116 | 0.080 |
Why?
|
Heterozygote | 2 | 2015 | 2787 | 0.080 |
Why?
|
Choroidal Neovascularization | 1 | 2012 | 363 | 0.080 |
Why?
|
Collagen | 1 | 2017 | 2638 | 0.080 |
Why?
|
Membrane Proteins | 3 | 2019 | 7856 | 0.080 |
Why?
|
Interferons | 2 | 2024 | 706 | 0.080 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 256 | 0.080 |
Why?
|
Comorbidity | 2 | 2020 | 10508 | 0.080 |
Why?
|
Mutation | 3 | 2024 | 30052 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2010 | 0.080 |
Why?
|
Osteoporotic Fractures | 1 | 2013 | 411 | 0.070 |
Why?
|
Bayes Theorem | 2 | 2016 | 2330 | 0.070 |
Why?
|
Demography | 1 | 2013 | 1648 | 0.070 |
Why?
|
Immunity, Innate | 4 | 2024 | 3065 | 0.070 |
Why?
|
GTPase-Activating Proteins | 1 | 2011 | 471 | 0.070 |
Why?
|
Interferon Regulatory Factors | 1 | 2009 | 261 | 0.070 |
Why?
|
Young Adult | 9 | 2021 | 59243 | 0.070 |
Why?
|
Lipase | 1 | 2010 | 325 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2021 | 58976 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2015 | 2691 | 0.070 |
Why?
|
Family Health | 1 | 2012 | 1257 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7827 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2651 | 0.070 |
Why?
|
Prolactin | 1 | 2009 | 625 | 0.070 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2011 | 633 | 0.070 |
Why?
|
Neoplasms | 4 | 2022 | 22170 | 0.070 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2009 | 899 | 0.070 |
Why?
|
Brain | 3 | 2024 | 27112 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2811 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3482 | 0.070 |
Why?
|
Immunoenzyme Techniques | 2 | 2001 | 1705 | 0.070 |
Why?
|
Genetics, Medical | 1 | 2009 | 334 | 0.070 |
Why?
|
Proteins | 3 | 2012 | 6032 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2015 | 4544 | 0.070 |
Why?
|
Adiponectin | 1 | 2012 | 1113 | 0.070 |
Why?
|
Up-Regulation | 3 | 2001 | 4124 | 0.070 |
Why?
|
Cell Line | 1 | 2020 | 15601 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2013 | 868 | 0.060 |
Why?
|
Body Weight | 2 | 2010 | 4618 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14605 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9606 | 0.060 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2024 | 29 | 0.060 |
Why?
|
Mental Disorders | 2 | 2016 | 6845 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1087 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1974 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2019 | 64680 | 0.060 |
Why?
|
Risk Assessment | 4 | 2015 | 23995 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3826 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1844 | 0.060 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1640 | 0.060 |
Why?
|
Exons | 3 | 2015 | 2391 | 0.060 |
Why?
|
Cell Movement | 3 | 2021 | 5203 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5840 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2018 | 11528 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2009 | 999 | 0.050 |
Why?
|
Heart Diseases | 1 | 2016 | 2781 | 0.050 |
Why?
|
Lymphocyte Subsets | 1 | 2024 | 310 | 0.050 |
Why?
|
Antigen Presentation | 2 | 2021 | 1251 | 0.050 |
Why?
|
Autoantigens | 2 | 2017 | 891 | 0.050 |
Why?
|
Odds Ratio | 4 | 2015 | 9646 | 0.050 |
Why?
|
Genes, Insect | 1 | 2003 | 264 | 0.050 |
Why?
|
Discriminant Analysis | 1 | 2002 | 222 | 0.050 |
Why?
|
PubMed | 1 | 2003 | 129 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10000 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4431 | 0.050 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2015 | 322 | 0.050 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2003 | 1058 | 0.050 |
Why?
|
Adipogenesis | 1 | 2024 | 368 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39106 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2011 | 2425 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2003 | 315 | 0.050 |
Why?
|
Antibiotic Prophylaxis | 1 | 2007 | 636 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 2 | 2019 | 829 | 0.050 |
Why?
|
Prognosis | 4 | 2019 | 29625 | 0.050 |
Why?
|
Multiple Sclerosis | 3 | 2014 | 3220 | 0.050 |
Why?
|
Cell Division | 1 | 2009 | 4465 | 0.050 |
Why?
|
Registries | 3 | 2015 | 8224 | 0.050 |
Why?
|
Genome, Fungal | 1 | 2002 | 203 | 0.050 |
Why?
|
Peptide T | 1 | 2000 | 3 | 0.050 |
Why?
|
Information Services | 1 | 2002 | 236 | 0.050 |
Why?
|
Chemokine CX3CL1 | 1 | 2001 | 63 | 0.050 |
Why?
|
Osteoarthritis | 1 | 2009 | 1063 | 0.050 |
Why?
|
Homozygote | 2 | 2018 | 1776 | 0.050 |
Why?
|
Organizations | 1 | 2022 | 171 | 0.050 |
Why?
|
Publications | 1 | 2003 | 194 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3537 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 629 | 0.050 |
Why?
|
Granzymes | 1 | 2022 | 277 | 0.050 |
Why?
|
Adolescent | 5 | 2021 | 88319 | 0.050 |
Why?
|
Plasma Cells | 1 | 2024 | 599 | 0.050 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2022 | 343 | 0.050 |
Why?
|
Blood Glucose | 2 | 2012 | 6391 | 0.040 |
Why?
|
Receptors, Interleukin-1 | 1 | 2021 | 262 | 0.040 |
Why?
|
Interleukin-13 | 1 | 2023 | 392 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6485 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 26125 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 3492 | 0.040 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 783 | 0.040 |
Why?
|
Fractures, Bone | 1 | 2012 | 2046 | 0.040 |
Why?
|
Injections, Intralesional | 1 | 2000 | 280 | 0.040 |
Why?
|
Spores, Fungal | 1 | 2000 | 90 | 0.040 |
Why?
|
Age of Onset | 2 | 2012 | 3305 | 0.040 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2000 | 198 | 0.040 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2021 | 306 | 0.040 |
Why?
|
Antigen-Antibody Complex | 1 | 2021 | 510 | 0.040 |
Why?
|
Medical Record Linkage | 1 | 2021 | 285 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2000 | 384 | 0.040 |
Why?
|
International Cooperation | 2 | 2020 | 1422 | 0.040 |
Why?
|
Gelatinases | 1 | 2019 | 88 | 0.040 |
Why?
|
Relaxation Therapy | 1 | 2000 | 181 | 0.040 |
Why?
|
Chromosome Disorders | 1 | 2022 | 497 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2020 | 367 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2023 | 3673 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2022 | 978 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 835 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2023 | 1149 | 0.040 |
Why?
|
Bone Density | 1 | 2012 | 3551 | 0.040 |
Why?
|
Netherlands | 2 | 2015 | 2221 | 0.040 |
Why?
|
Prevalence | 1 | 2016 | 15732 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 727 | 0.040 |
Why?
|
Obesity | 3 | 2014 | 12947 | 0.040 |
Why?
|
Calcitonin Gene-Related Peptide | 2 | 1998 | 323 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4398 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8002 | 0.040 |
Why?
|
Transplantation Chimera | 1 | 2001 | 594 | 0.040 |
Why?
|
Pharyngitis | 1 | 2000 | 219 | 0.040 |
Why?
|
HLA-B27 Antigen | 1 | 2018 | 63 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2002 | 755 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2024 | 1078 | 0.040 |
Why?
|
Globulins | 1 | 1997 | 19 | 0.040 |
Why?
|
Triose-Phosphate Isomerase | 1 | 1997 | 45 | 0.040 |
Why?
|
Fructose-Bisphosphate Aldolase | 1 | 1997 | 51 | 0.040 |
Why?
|
Body Mass Index | 2 | 2018 | 12953 | 0.040 |
Why?
|
Alaska | 1 | 2017 | 69 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 675 | 0.040 |
Why?
|
Systems Biology | 1 | 2021 | 481 | 0.040 |
Why?
|
Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2022 | 1386 | 0.040 |
Why?
|
Ecological Systems, Closed | 1 | 1997 | 3 | 0.040 |
Why?
|
Regression Analysis | 2 | 2019 | 6343 | 0.040 |
Why?
|
Life Support Systems | 1 | 1997 | 11 | 0.040 |
Why?
|
Penicillins | 1 | 2020 | 402 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2000 | 695 | 0.040 |
Why?
|
Excipients | 1 | 1997 | 98 | 0.040 |
Why?
|
Plants, Edible | 1 | 1997 | 30 | 0.040 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 1997 | 110 | 0.040 |
Why?
|
Nitrogen Fixation | 1 | 1997 | 63 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 957 | 0.040 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 587 | 0.030 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 59 | 0.030 |
Why?
|
Static Electricity | 1 | 1997 | 261 | 0.030 |
Why?
|
Receptors, CXCR5 | 1 | 2017 | 88 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10766 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2001 | 2469 | 0.030 |
Why?
|
Alcohol Oxidoreductases | 1 | 1997 | 169 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2003 | 3810 | 0.030 |
Why?
|
Racemases and Epimerases | 1 | 1997 | 114 | 0.030 |
Why?
|
Vimentin | 1 | 2017 | 255 | 0.030 |
Why?
|
Pruritus | 1 | 2000 | 380 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 191 | 0.030 |
Why?
|
Collagen Type IV | 1 | 2016 | 126 | 0.030 |
Why?
|
Physical Fitness | 1 | 2000 | 743 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2000 | 11076 | 0.030 |
Why?
|
Kinetics | 2 | 2014 | 6374 | 0.030 |
Why?
|
Mathematics | 1 | 1997 | 707 | 0.030 |
Why?
|
Mice, SCID | 1 | 2001 | 2626 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6403 | 0.030 |
Why?
|
Neuropharmacology | 1 | 1995 | 20 | 0.030 |
Why?
|
Cell Polarity | 1 | 2019 | 637 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 1997 | 189 | 0.030 |
Why?
|
Biological Evolution | 1 | 2021 | 1071 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2000 | 1007 | 0.030 |
Why?
|
Endopeptidases | 1 | 2019 | 774 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 330 | 0.030 |
Why?
|
Receptors, Neurotransmitter | 1 | 1995 | 174 | 0.030 |
Why?
|
Nitrogen | 1 | 1997 | 348 | 0.030 |
Why?
|
Drosophila | 1 | 2003 | 1495 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3272 | 0.030 |
Why?
|
Fasting | 2 | 2012 | 1603 | 0.030 |
Why?
|
Chronic Disease | 2 | 2023 | 9318 | 0.030 |
Why?
|
Neurophysiology | 1 | 1995 | 144 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 1995 | 188 | 0.030 |
Why?
|
Chaperonins | 1 | 2014 | 58 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2016 | 248 | 0.030 |
Why?
|
Cell Count | 1 | 1999 | 1835 | 0.030 |
Why?
|
Normal Distribution | 1 | 2015 | 272 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22169 | 0.030 |
Why?
|
Nerve Fibers | 1 | 1998 | 708 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2461 | 0.030 |
Why?
|
Cholesterol, HDL | 2 | 2012 | 1814 | 0.030 |
Why?
|
Complement C3b | 1 | 2014 | 97 | 0.030 |
Why?
|
Peripheral Nerves | 2 | 1995 | 479 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8708 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2018 | 16981 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2019 | 823 | 0.030 |
Why?
|
Radiography | 2 | 2015 | 6965 | 0.030 |
Why?
|
Drosophila melanogaster | 1 | 2003 | 1712 | 0.030 |
Why?
|
Codon, Nonsense | 1 | 2015 | 285 | 0.030 |
Why?
|
Hematinics | 1 | 2017 | 282 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2018 | 2265 | 0.030 |
Why?
|
Pressure | 1 | 1997 | 1154 | 0.030 |
Why?
|
Vietnam | 1 | 2014 | 409 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12059 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 2017 | 652 | 0.030 |
Why?
|
Arginine | 1 | 2017 | 934 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2003 | 1456 | 0.030 |
Why?
|
Lod Score | 1 | 2014 | 600 | 0.030 |
Why?
|
Nepal | 1 | 2014 | 305 | 0.030 |
Why?
|
Protein Folding | 1 | 1997 | 870 | 0.030 |
Why?
|
Receptors, CCR5 | 1 | 2015 | 486 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2141 | 0.030 |
Why?
|
Calcium Channels | 1 | 2017 | 620 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1055 | 0.030 |
Why?
|
Finland | 1 | 2014 | 607 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 103 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2016 | 11118 | 0.030 |
Why?
|
Cadherins | 1 | 2018 | 903 | 0.030 |
Why?
|
Eye | 1 | 2017 | 712 | 0.030 |
Why?
|
Cryopreservation | 1 | 2018 | 728 | 0.030 |
Why?
|
Particle Size | 1 | 1997 | 1648 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2001 | 2385 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1084 | 0.030 |
Why?
|
Benchmarking | 1 | 2019 | 1045 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2003 | 2803 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2017 | 754 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 204 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2012 | 14 | 0.030 |
Why?
|
Glycosylation | 1 | 2015 | 1098 | 0.030 |
Why?
|
Complement C3-C5 Convertases, Alternative Pathway | 1 | 2011 | 1 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2014 | 931 | 0.020 |
Why?
|
Leprosy | 1 | 1992 | 126 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 2012 | 122 | 0.020 |
Why?
|
Exercise | 2 | 2000 | 5890 | 0.020 |
Why?
|
Interleukins | 1 | 2017 | 782 | 0.020 |
Why?
|
Interferon-beta | 1 | 2014 | 345 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2049 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2122 | 0.020 |
Why?
|
Lymphoma | 1 | 2001 | 1901 | 0.020 |
Why?
|
Sample Size | 1 | 2015 | 841 | 0.020 |
Why?
|
Spectrin | 1 | 2012 | 170 | 0.020 |
Why?
|
Republic of Korea | 1 | 2014 | 590 | 0.020 |
Why?
|
Sweden | 1 | 2014 | 1379 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2013 | 233 | 0.020 |
Why?
|
Pakistan | 1 | 2012 | 292 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2012 | 659 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 992 | 0.020 |
Why?
|
Bone Marrow | 1 | 2021 | 2911 | 0.020 |
Why?
|
Foot | 1 | 2015 | 575 | 0.020 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2012 | 158 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 993 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2013 | 321 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2012 | 518 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2273 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3087 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2013 | 585 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2015 | 1186 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 34 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2017 | 15500 | 0.020 |
Why?
|
Ikaros Transcription Factor | 1 | 2012 | 232 | 0.020 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
Femur Neck | 1 | 2012 | 314 | 0.020 |
Why?
|
Influenza A virus | 1 | 2014 | 458 | 0.020 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2010 | 102 | 0.020 |
Why?
|
China | 1 | 2016 | 2369 | 0.020 |
Why?
|
Antigens, CD19 | 1 | 2013 | 424 | 0.020 |
Why?
|
Child, Preschool | 3 | 2017 | 42230 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2015 | 1258 | 0.020 |
Why?
|
Italy | 1 | 2012 | 842 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2014 | 20098 | 0.020 |
Why?
|
Folic Acid | 1 | 2017 | 1323 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3466 | 0.020 |
Why?
|
Probability | 1 | 2015 | 2477 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 2011 | 464 | 0.020 |
Why?
|
Hand | 1 | 2015 | 902 | 0.020 |
Why?
|
Needs Assessment | 1 | 2015 | 1139 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2850 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1726 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 174 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2014 | 726 | 0.020 |
Why?
|
Neprilysin | 1 | 2012 | 478 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3724 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2012 | 1178 | 0.020 |
Why?
|
Life Style | 1 | 2000 | 3917 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1600 | 0.020 |
Why?
|
Germany | 1 | 2011 | 875 | 0.020 |
Why?
|
Internet | 1 | 2001 | 3092 | 0.020 |
Why?
|
Arthrography | 1 | 2009 | 150 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8631 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2568 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2003 | 2895 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 410 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1612 | 0.020 |
Why?
|
Siblings | 1 | 2012 | 825 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2002 | 2578 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21012 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2000 | 4028 | 0.020 |
Why?
|
Body Size | 1 | 2010 | 463 | 0.020 |
Why?
|
Databases, Factual | 2 | 2001 | 7967 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 733 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2000 | 2491 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2003 | 4026 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2598 | 0.020 |
Why?
|
Multigene Family | 1 | 2010 | 1076 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7212 | 0.020 |
Why?
|
Health Status | 2 | 2010 | 4077 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 1997 | 2319 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 3968 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2206 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2014 | 1555 | 0.020 |
Why?
|
Osteogenesis | 1 | 2013 | 1273 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4652 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5871 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2014 | 875 | 0.020 |
Why?
|
Gene Amplification | 1 | 2010 | 1089 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1336 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1651 | 0.010 |
Why?
|
International Classification of Diseases | 1 | 2010 | 909 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2490 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2014 | 2244 | 0.010 |
Why?
|
Glycoproteins | 1 | 2012 | 2203 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1405 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2012 | 2448 | 0.010 |
Why?
|
Zebrafish | 1 | 2014 | 3007 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2010 | 1835 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4575 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2009 | 1588 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15266 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12341 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2012 | 1879 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12974 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2014 | 3807 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1896 | 0.010 |
Why?
|
Escherichia coli | 1 | 2014 | 4217 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11121 | 0.010 |
Why?
|
Ligases | 1 | 2003 | 333 | 0.010 |
Why?
|
Myocardium | 1 | 2014 | 4726 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1545 | 0.010 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2003 | 305 | 0.010 |
Why?
|
Osteopontin | 1 | 2003 | 301 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6377 | 0.010 |
Why?
|
Databases as Topic | 1 | 2003 | 473 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 1997 | 4420 | 0.010 |
Why?
|
Parkinson Disease | 1 | 2014 | 2877 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5791 | 0.010 |
Why?
|
Lipids | 1 | 2010 | 3341 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 39967 | 0.010 |
Why?
|
Neurons | 1 | 2018 | 9463 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2012 | 3963 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 3708 | 0.010 |
Why?
|
Infant | 1 | 2000 | 36192 | 0.010 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 1998 | 180 | 0.010 |
Why?
|
Insulin | 1 | 2012 | 6596 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 427 | 0.010 |
Why?
|
Tilapia | 1 | 1997 | 24 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1479 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4671 | 0.010 |
Why?
|
Biomass | 1 | 1997 | 137 | 0.010 |
Why?
|
Entropy | 1 | 1996 | 210 | 0.010 |
Why?
|
Blotting, Western | 1 | 2003 | 5035 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6132 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1624 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9486 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 1998 | 1076 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2014 | 8599 | 0.010 |
Why?
|
United States | 1 | 2020 | 72334 | 0.010 |
Why?
|
Oxygen | 1 | 2003 | 4227 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8465 | 0.010 |
Why?
|
Periodicals as Topic | 1 | 2001 | 1463 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17635 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2003 | 12463 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1996 | 3769 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14666 | 0.000 |
Why?
|